Peritoneal Dialysis in Patients Supported by Left Ventricular Assist Device
Artificial Organs · 2025
DOI: 10.1111/aor.14970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Zurab Darbaidze und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Heart-Assist Devices, Peritoneal Dialysis, Heart Failure, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Terminal heart failure is often associated with end‐stage kidney disease. Due to advantages concerning patient independence, peritoneal dialysis (PD) is an alternative to conventional hemodialysis treatment. As left ventricular assist device implantations continuously increase, data on combined PD and LVAD is rare. We present the first and largest cohort study on this exclusive patient cohort.
Methods
A retrospective study was conducted on patients who underwent LVAD implantation at a high‐volume heart failure center from 2000 to 2024. Adverse events were analyzed according to the INTERMACS classification.
Results
A total of nine patients were identified as undergoing PD on LVAD therapy. Mean age at the time of LVAD implantation was 67 years. Main cause of kidney disease was cardio‐renal syndrome (67%). In all patients, PD therapy was established before LVAD implantation. Mean time on PD before LVAD implantation was 72 months. None of the patients were weaned from dialysis nor were converted to conventional dialysis. Four patients experienced driveline infection. Three patients suffered an infection of their PD catheter. A combination of PD and DL infection was detected in two cases. None of these infections were associated with the same pathogens. Mean survival after LVAD + PD was 56.5 months.
Conclusion
Peritoneal dialysis has advantages over hemodialysis including fewer bloodstream infections, fewer hemodynamic shifts, and the comfort of the ambulant setting. This study illustrates that PD in LVAD patients is feasible and long‐term support up to several years is achievable without major complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
- Department of Neurology, Hannover Medical School, Hannover, Germany.
ORCID-Profile: Günes Dogan, Jasmin S Hanke
Zitieren
APA
Darbaidze, Z., Schmack, B., Dogan, G., Merzah, A. S., Gabriel, M. M., Görler, A., Popov, A. F., Weymann, A., Ruhparwar, A., Schmitto, J. D., & Hanke, J. S. (2025). Peritoneal Dialysis in Patients Supported by Left Ventricular Assist Device. Artificial Organs. https://doi.org/10.1111/aor.14970
Vancouver
Darbaidze Z, Schmack B, Dogan G, Merzah AS, Gabriel MM, Görler A, et al. Peritoneal Dialysis in Patients Supported by Left Ventricular Assist Device. Artificial Organs. 2025. doi:10.1111/aor.14970
BibTeX
@article{Darbaidze2025,
author = {Darbaidze, Zurab and Schmack, Bastian and Dogan, Günes and Merzah, Ali Saad and Gabriel, Maria M and Görler, Adelheid and Popov, Aron-Frederik and Weymann, Alexander and Ruhparwar, Arjang and Schmitto, Jan D and Hanke, Jasmin S},
title = {Peritoneal Dialysis in Patients Supported by Left Ventricular Assist Device},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14970}
}
EUVIMED